These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Live attenuated varicella vaccine use in immunocompromised children and adults. Gershon AA; Steinberg SP; Gelb L Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495 [TBL] [Abstract][Full Text] [Related]
25. Varicella-zoster virus. Prospects for active immunization. Gershon AA Am J Clin Pathol; 1978 Jul; 70(1 Suppl):170-4. PubMed ID: 210654 [TBL] [Abstract][Full Text] [Related]
26. Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen. Takahashi M; Iketani T; Sasada K; Hara J; Kamiya H; Asano Y; Baba K; Shiraki K J Infect Dis; 1992 Aug; 166 Suppl 1():S58-62. PubMed ID: 1320651 [TBL] [Abstract][Full Text] [Related]
27. Live attenuated varicella vaccine. Gershon AA Annu Rev Med; 1987; 38():41-50. PubMed ID: 3034136 [TBL] [Abstract][Full Text] [Related]
28. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864 [No Abstract] [Full Text] [Related]
30. Varicella vaccine: decisions a little nearer. McIntosh K N Engl J Med; 1984 May; 310(22):1456-7. PubMed ID: 6325911 [No Abstract] [Full Text] [Related]
31. Live varicella vaccine: the third act? Plotkin SA Vaccine; 1986 Jun; 4(2):74. PubMed ID: 3014771 [No Abstract] [Full Text] [Related]
32. Antibodies to varicella-zoster virus glycoproteins I, II, and III in leukemic and healthy children. LaRussa PS; Gershon AA; Steinberg SP; Chartrand SA J Infect Dis; 1990 Sep; 162(3):627-33. PubMed ID: 2167335 [TBL] [Abstract][Full Text] [Related]
33. Worldwide experience with the Oka-strain live varicella vaccine. Andre FE Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468 [TBL] [Abstract][Full Text] [Related]
34. Herpes zoster in an adult recipient of live attenuated varicella vaccine. Hammerschlag MR; Gershon AA; Steinberg SP; Clarke L; Gelb LD J Infect Dis; 1989 Sep; 160(3):535-7. PubMed ID: 2547882 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years. Oka T; Iseki K; Oka R; Sakuma S; Yoshioka H; Takahashi M Biken J; 1984 Sep; 27(2-3):103-9. PubMed ID: 6100045 [TBL] [Abstract][Full Text] [Related]
36. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982. Horiuchi K Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055 [TBL] [Abstract][Full Text] [Related]
37. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment. Balfour HH Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447 [TBL] [Abstract][Full Text] [Related]
38. Review of the Varilrix varicella vaccine. Chiu SS; Lau YL Expert Rev Vaccines; 2005 Oct; 4(5):629-43. PubMed ID: 16221065 [TBL] [Abstract][Full Text] [Related]
39. Varicella zoster infection in adults: a preventable disease. Megged O; Schlesinger Y Isr Med Assoc J; 2009 May; 11(5):306-7. PubMed ID: 19637510 [No Abstract] [Full Text] [Related]